Health Tech

Find More: Biotech Pharma
- Advertisement -
Ad imageAd image
EM Systems and Good Cycle Systems Merge Systems

EM Systems Co., Ltd., a provider of ICT system solutions to medical institutions and pharmacies nationwide, has consolidated the sales and service operations of its insurance pharmacy support system business,…

FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery in the Life Science AI Field (AI Drug Discovery Area)

FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…

NEC and biomy partner to develop and expand analysis platform in the digital pathology field

NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred…

Primo Partners with SHINE to Advance Precision Oncology in Asia Pacific

Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"),…

CN Bio Partners with Primetech to Establish Distribution Channel for OOC Solutions in Japan

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that…

Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope

Daiichi Sankyo Company, Ltd  announced  that it will pay Glycotope $132.5 million…

FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery in the Life Science AI Field (AI Drug Discovery Area)

FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…

NEC and biomy partner to develop and expand analysis platform in the digital pathology field

NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred…

Primo Partners with SHINE to Advance Precision Oncology in Asia Pacific

Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"),…

CN Bio Partners with Primetech to Establish Distribution Channel for OOC Solutions in Japan

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that…

Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope

Daiichi Sankyo Company, Ltd  announced  that it will pay Glycotope $132.5 million…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community